Kindred Biosciences Inc. (KIN)

8.27
NASDAQ : Health Technology
Prev Close 8.85
Day Low/High 8.27 / 8.84
52 Wk Low/High 8.05 / 15.75
Avg Volume 217.40K
Exchange NASDAQ
Shares Outstanding 38.85M
Market Cap 343.87M
EPS -1.60
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

The 2017 Gad Value Investment Fund, Part 2

The 2017 Gad Value Investment Fund, Part 2

The second half of our value-stocks portfolio for the New Year.

2 Bargains That Are Hiding in Plain Sight

2 Bargains That Are Hiding in Plain Sight

Kindred Biosciences and GM may be 'too cheap not to own.'

Winning Value Portfolio Is Set to Beat the Market

Winning Value Portfolio Is Set to Beat the Market

Even if the markets were to take a dive, the strength of our holdings will prevail.

Good Stocks Can Come in Small Packages

Good Stocks Can Come in Small Packages

These 3 names may not draw attention, but they can draw profits.

Value Portfolio Performs Well Amid Brexit Turmoil

A group of seven to 15 securities, if carefully selected, can provide all the diversification an investor needs.

It's Patient Capital's Time to Prosper

Brexit has caused active investors to flee and created an opportunity for those who are patient.

Portfolio Patience Is a Virtue

The energy rally is a good example.

Two Little Gems Are Hidden Amid Small-Caps

Sometimes, the under-research companies offer the biggest opportunities.

5 Picks for a Winning Value Portfolio, Part 2

Investors should see this selection as one part of a multi-year investment program.

As Calendar Year Dwindles, So Does Logic

Investors dump losing positions to start 'fresh' in 2016.

I Was Too Early to the Dance on Oil Stocks

My Winning Value Portfolio didn't live up to its name in 2015.

Winning Value Portfolio Is Anything But

August was a month to forget, dragged down by the energy names.

Winning Value Portfolio Taking a Hit

Despite portfolio performance, valuations of most of the stocks appear to be as compelling as ever.

Need for Patience Is Evident in Value Portfolio

Only Chenier Energy was a winner among these 10 names. 

Value Portfolio Benefits From Patience

'Doing nothing' delivered in April.

Winning Value Portfolio Needs Patience

A weak March showing isn't catastrophic, but be ready for more pain.

A Winning Value Portfolio Update

Despite underperforming so far, the portfolio is well undervalued.

A Winning Value Portfolio Update

Off to a slow start, but time is still on our side in 2015.

2015 Gad Value Portfolio Revealed, Part 2

All that matters is valuation and potential upside.

Cheap Just Got Cheaper

A probabilistic biotech play.

Slim Pickings in Latest 13F Filings

Many value investors are making more concentrated bets.

Consider Drug Stocks for Animals

Bill Ackman is betting on Zoetis -- and you should, too.

Consider Adopting Kindred Biosciences

The stock's recent decline makes upside even more appealing.

You Can Ignore My Stock Picks

The 15% jump yesterday means little in my scheme of things.

Another Gem for the Biotech Basket

Amid the basket's impressive performance, I'm adding Minerva.

Profit From the Fed's Words

When the Fed knocks down certain market sectors, we value investors know what to do.

Building a Biotech Basket

Borrowing a page from a master investor's playbook.

Kindred: Potential in Animal Healthcare

Two commercially-viable products could spur enormous growth.